Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present GB Sciences, Inc. (OTC: GBLX).

Full DD Report for GBLX

You must become a subscriber to view this report.


Recent News from (OTC: GBLX)

Pot stocks perk up premarket
Cannabis stocks are showing some life premarket. Cronos Group (NASDAQ: CRON ) is up  24%  on robust volume, Canopy Growth (NYSE: CGC ) is up  7%  on increased volume and Tilray (NASDAQ: TLRY ) is up  11%  on average volume. More news on: Cronos Group, Inc., Ca...
Source: SeekingAlpha
Date: September, 05 2018 07:50
Citron bearish on Tilray due to valuation; shares up 9%
Citron Research, a buyer of pot stock Tilray ( TLRY +9.4% ) up to $45, is now bearish with a fair value target of $26, calling it "by far the most expensive in the space." The stock is currently exchanging hands at $72 up over four-fold from its IPO price of $17. More news on: Tilray, In...
Source: SeekingAlpha
Date: September, 04 2018 12:19
Profit-taking pressures Tilray, down 4% premarket
Tilray (NASDAQ: TLRY ) slips  4%  premarket on light volume as investors take money off the table after the stock's ~ 160%  run-up since touching $24 on August 14. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stocks news, Consumer sto...
Source: SeekingAlpha
Date: August, 30 2018 08:09
Trump's secret war on weed - BuzzFeed
The administration's Marijuana Policy Coordination Committee is aiming to combat public support for marijuana and throw a negative spin on state legalization initiatives, writes Dominic Holden. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stock...
Source: SeekingAlpha
Date: August, 29 2018 13:51
Beverage giants eye Canadian cannabis players
The large investment by Constellation Brands ( STZ +1.1% ) in Canopy Growth Corp. ( CGC +3.8% ) is still reverberating around the beverage industry as some of the larger names scramble to keep up. More news on: Constellation Brands, Inc., Canopy Growth Corporation, Anheuser-Busch InB...
Source: SeekingAlpha
Date: August, 29 2018 10:42
Diageo eyeing cannabis-infused beverages
Bloomberg reports that top alcohol producer Diageo Plc (NYSE: DEO ), aiming to boost growth and fend off competitors, is in discussions with at least three major Canadian producers to add cannabis-infused beverages to its portfolio. More news on: Diageo plc, Molson Coors Brewing Company,...
Source: SeekingAlpha
Date: August, 24 2018 07:26
The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership
The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership Canada NewsWire BATON ROUGE, La., Aug. 23, 2018 In Partnership with GB Sciences and LSU AgCent...
Source: Canada Newswire
Date: August, 23 2018 05:30
U.S. pot market could be worth $47B - RBC
In a note , RBC Capital Markets says that legal sales of marijuana in the U.S. are catching up to beer and wine, potentially reaching $47B in ten years, implying a 17% CAGR. More news on: Aurora Cannabis Inc., Aero Grow International, Inc., Agritek Holdings, Inc., Healthcare stocks news, ...
Source: SeekingAlpha
Date: August, 22 2018 09:55
Weed firms set for bullish action ahead of start of Canada recreational pot market
Cannabis-related stocks may see broad buying today as they announce supply agreements with retail operations ahead of the launch of the adult-use recreational cannabis market in Canada on October 17. Cronos Group (NASDAQ: CRON ) and Tilray (NASDAQ: TLRY ) have already announced deals. Both a...
Source: SeekingAlpha
Date: August, 21 2018 08:07
Robust Growth in Cannabidiol (CBD) and Hemp Market Fueling Strong Optimistic Outlook
Palm Beach, FL – (August 21, 2018) – The increasing demand for Cannabidiol (CBD) and Hemp based products is expected to push both markets into new territories in terms of sales value in the next coming years. According to a report published by New Frontier Data , the U.S. CBD indu...
Source: MarketNewsUpdates.com
Date: August, 21 2018 08:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-110.1950.19490.19660.185590,883
2018-12-100.2010.19630.20250.1851469,985
2018-12-070.17020.20060.203250.1702519,888
2018-12-060.180.20350.20350.1701654,269
2018-12-050.2040.200.2050.191746,210

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11352,960590,88359.7343Short
2018-12-10135,445469,98528.8190Cover
2018-12-07198,317519,88838.1461Short
2018-12-06184,478654,26928.1960Cover
2018-12-04146,423746,06019.6262Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GBLX.


About GB Sciences, Inc. (OTC: GBLX)

Logo for GB Sciences, Inc. (OTC: GBLX)

The Company seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical grade cannabis, cannabis concentrates and cannabinoid therapies. Although we believe that maximum shareholder value will ultimately be achieved through the development, production and marketing of certified cannabinoid medicines, therapies and treatments, in order to generate cash flow and near term profitability, we intend to cultivate and dispense cannabis for medical purposes in both Nevada and other states which permit such sales and in which we and our operating partners are able to obtain cultivation and dispensing licenses. We seek to become a trusted producer of consistent and efficacious medicinal strains and products, combining both cannabinoids and terpenes, which we intend to market in those states within the United States and in other countries where the sale of medical cannabis products are permitted. In addition, subject to obtaining Food and Drug Administrative FDA certification, we intend to market our cannabinoid based drug discoveries on a world wide basis.

 

Contact Information

 

 

Current Management

  • John Poss / President, CEO
    • Mr. Poss has over years of experience working as a consultant to companies facing major transitions and transformations. Mr. Poss began his career in the Washington, D.C. office of Arthur Andersen amp Co. and has served as Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Technology Officer of both public and private companies in such diverse industries as homebuilding, mining, telecommunications, manufacturing, logistics, construction lending and mortgage banking. For the past three years Mr. Poss served as Chief Executive Officer of Experiential Teaching Online Corp., an educational content developer and for four years prior thereto owned and operating his own consulting firm. Mr. Poss has also has worked extensively internationally, successfully negotiating agreements in countries throughout Asia, Europe and the Americas. Mr. Poss graduated from the University of Texas in with a degree in accounting.
  • Ksenia Griswold / CFO, Vice President
  • Leslie Bocskor /
    • Mr. Bocskor, age , combines two years of experience in the cannabis industry and a total of years in senior management in the financial industry. Since June , Mr. Bocskor has served as the President of Venture Catalyst LLC, a consulting company. From February through September , Mr. Bocskor was employed in the investment banking division of Network One Financial, Inc. From May through June , Mr. Bocskor was Managing Partner of Lenox Hill Partners, LLC an advisory firm that focused on corporate finance and business consulting. Currently, Mr. Bocskor serves as the Chairman of the Board of The Nevada Cannabis Industry Association, a trade association working to establish an exemplary legal Cannabis Industry in the State of Nevada. Mr. Bocskor is also Chairman of the Board for the Figment Project, an arts and cultural organization. The board of directors believes that Mr. Bocskor s experience in the legal cannabis industry and extensive experience in the financial markets will be critical in supporting the Company s growth plans.
  • John Poss /
    • Mr. Poss has over years of experience working as a consultant to companies facing major transitions and transformations. Mr. Poss began his career in the Washington, D.C. office of Arthur Andersen amp Co. and has served as Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Technology Officer of both public and private companies in such diverse industries as homebuilding, mining, telecommunications, manufacturing, logistics, construction lending and mortgage banking. For the past three years Mr. Poss served as Chief Executive Officer of Experiential Teaching Online Corp., an educational content developer and for four years prior thereto owned and operating his own consulting firm. Mr. Poss has also has worked extensively internationally, successfully negotiating agreements in countries throughout Asia, Europe and the Americas. Mr. Poss graduated from the University of Texas in with a degree in accounting.
  • Andrea SmallHoward /
  • Shane Terry /
    • Mr. Terry is an independent consultant provides advisory services to Medical Marijuana Establishments MME s in Nevada and other states. He served as a CEO of NuVeda NMS, LLC, a company that operates marijuana dispensaries in Nevada, from until . He is also a former President of the Nevada Dispensary Association From until Mr. Terry served as F Weapons Officer and Instructor Pilot. Mr. Terry is a decorated veteran of the United States Air Force, whose career as an Officer and F fighter pilot included earning two Air Medals for combat action over Iraq and Afghanistan while leading his team to three Air Force Outstanding Unit awards. The Company is currently discussing compensation arrangement with Mr. Terry pursuant to which he will serve as the Company s Board Member.

Current Share Structure

  • Market Cap: $91,609,801 - 03/09/2018
  • Authorized: 200,000,000 - 02/05/2018
  • Issue and Outstanding: 155,931,576 - 02/14/2018
  • Float: 6,631,667 - 01/22/2015

 


Recent Filings from (OTC: GBLX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: January, 12 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: December, 22 2017
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: December, 22 2017
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: November, 28 2017
Quarterly Report - GB Sciences, Inc 10-Q September 30, 2017
Filing Type: Quarterly Report - GB Sciences, Inc 10-Q September 30, 2017Filing Source: OTC Markets
Filing Date: November, 20 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017

 

 


Daily Technical Chart for (OTC: GBLX)

Daily Technical Chart for (OTC: GBLX)


Stay tuned for daily updates and more on (OTC: GBLX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GBLX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GBLX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GBLX and does not buy, sell, or trade any shares of GBLX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/